ClinicalTrials.gg
WithdrawnNCT02330861Updated Aug 2, 2018

Relationship Between Pressure and Flow Velocity on Coronary Physiology

An interventional study of combowire and IVUS in Coronary Stenosis, sponsored by Hyogo Medical University. Withdrawn at 1 site in Japan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-02.

Sponsored by Hyogo Medical University · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Coronary Stenosis with a site in Japan — 2 open to participants now, 3 under way, none of them phase 3. Coronary Stenosis · Japan.

Enrollment
11th of 11
0 · median 240
Started
2014
the only one that year
No phase
10 of 14
2 open now
Registered
8th of 14
by date
Lead sponsor
1 of 14
Hyogo Medical University

Among the 14 studies in Coronary Stenosis with a site in Japan, this one is the 11th largest by enrollment of the 11 interventional ones that give a count, is the only one that started in 2014, is one of 10 with no phase, and was the 8th registered.

Coronary Stenosis

326 studies on the registry are indexed under Coronary Stenosis; 57 are open to participants now.

Browse Coronary Stenosis studies →

Open to participants now

2 of the 14 studies in Coronary Stenosis with a site in Japan are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →

Who these studies take

Of the 40 Coronary Stenosis studies recruiting now, 33 (83%) set no upper age limit and 3 (8%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Coronary Stenosis with a site in Japan, or all of them as a file.
02

Study summary

Subjects are patients who are planned to do percutaneous coronary intervention for coronary stenosis in the left circumflex artery without other stenosis in the left ascending artery and the right coronary artery, or a patient with normal coronary artery. Immediately after coronary angiography or percutaneous coronary intervention, the investigators will evaluate for coronary hemodynamics by distribution of wave intensity which is calcurated by coronary pressure and flow velocity with Combowire in each coronary segment. Also, they will assess coronary morphology by View It in each coronary segment.

Read the detailed description

Combowire (Volcano Therapeutics Inc., CA, USA) is a 0.014 inch pressure/Doppler sensor-tipped-guidewire which can measure coronary pressure and flow velocity.

View It (Terumo Co., Japan) is a guide catheter with intravascular ultrasound which can measure coronary morphology such as vessel diamter.

03

Conditions studied

  • Coronary Stenosis

Browse trials for

Keywords

  • Coronary Circulation
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A patient who are planned to do percutaneous coronary intervention for stenosis in the left circumflex artery without any lesions in other coronary arteries
  • Or a patient who is performed coronary angiography without significant stenosis lesion in 3-coronary vessel

Exclusion criteria

Exclusion Criteria:

  • A patient with coronary stenosis with LAD
  • Hemodialysis
  • Acute coronary syndrome
  • Congestive heart failure
  • A patient with shock vitals
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Other
    Normal coronary artery

    Device: combowire and IVUS

Interventions

  • Devicecombowire and IVUS
06

What researchers measure

Primary outcomes

  1. Wave intensity

    Time frame: Immediately after coronary angiography or percutaneous coronary intervention

Secondary outcomes

  1. Coronary pressure

    Time frame: Immediately after coronary angiography or percutaneous coronary intervention

  2. Flow velocity

    Time frame: Immediately after coronary angiography or percutaneous coronary intervention

  3. Vessel diameter

    Time frame: Immediately after coronary angiography or percutaneous coronary intervention

07

Study locations

1 site
  • Hyogo College of Medicine
    Nishinomiya, 6638501, Japan
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Dec 2014, a primary completion of Feb 2017 and a completion of Feb 2017. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 24, 2014
First posted
Jan 5, 2015
Start
Dec 2014
Primary completionActual
Feb 2017
CompletionActual
Feb 2017
Last update
Aug 2, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02330861
Lead sponsor
Hyogo Medical University
Responsible party
Kenichi Fujii (Relationship between pressure and flow velocity on coronary physiology, Hyogo Medical University) — Principal investigator
First posted
Jan 5, 2015
Start date
Dec 2014
Primary completion
Feb 2017
Completion
Feb 2017
Last update
Aug 2, 2018
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion